| Visionworks Doctors Of Optometry | |
| 254 Indian Lake Blvd, Ste 100, Hendersonville, Tennessee 37075 | |
| (615) 822-0446 |
| Name | Visionworks Doctors Of Optometry |
|---|---|
| Organization Name | Dr. Mark Lynn & Associates, Pllc |
| Location | 254 Indian Lake Blvd, Ste 100, Hendersonville, Tennessee 37075 |
| Type | Eyewear Supplier (Equipment, not the service) |
| Phone | (615) 822-0446 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
The Honourable Gary Goodyear, Minister of State (Science and Technology), announced the launch of a new Genome Canada program designed to move genomics-based solutions from laboratories to the marketplace.
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
A bipartisan group of lawmakers will make a lame-duck push at passing a previously released deficit reduction plan.
› Verified 6 days ago
| NPI Number | 1003194556 |
| Organization Name | DR. MARK LYNN & ASSOCIATES, PLLC |
| Doing Business As | VISIONWORKS DOCTORS OF OPTOMETRY |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 254 Indian Lake Blvd.,, Suite 100, Hendersonville, TN 37075 |
| Phone Number | 615-822-0446 |
News Archive
Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
The Honourable Gary Goodyear, Minister of State (Science and Technology), announced the launch of a new Genome Canada program designed to move genomics-based solutions from laboratories to the marketplace.
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
A bipartisan group of lawmakers will make a lame-duck push at passing a previously released deficit reduction plan.
› Verified 6 days ago
| NPI Number | 1225794449 |
| Organization Name | TN DOCTORS OF OPTOMETRY, PLLC |
| Type | Eyewear Supplier (Equipment, not the service) |
| Address | 254 Indian Lake Blvd, Suite 100, Hendersonville, TN 37075 |
| Phone Number | 615-822-0446 |
News Archive
Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
The Honourable Gary Goodyear, Minister of State (Science and Technology), announced the launch of a new Genome Canada program designed to move genomics-based solutions from laboratories to the marketplace.
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
A bipartisan group of lawmakers will make a lame-duck push at passing a previously released deficit reduction plan.
› Verified 6 days ago
News Archive
Cedars-Sinai Heart Institute researchers have found in an initial clinical trial that a drug typically prescribed for erectile dysfunction or pulmonary hypertension restores blood flow to oxygen-starved muscles in patients with a type of muscular dystrophy that affects males, typically starting in childhood or adolescence.
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
The Honourable Gary Goodyear, Minister of State (Science and Technology), announced the launch of a new Genome Canada program designed to move genomics-based solutions from laboratories to the marketplace.
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
A bipartisan group of lawmakers will make a lame-duck push at passing a previously released deficit reduction plan.
› Verified 6 days ago
Visionworks Doctors Of Optometry Type: Eyewear Supplier (Equipment, not the service) Location: 254 Indian Lake Blvd, Hendersonville, Tennessee 37075 Phone: (615) 822-0446 | |
Ed Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 106a Free Hill Rd, Hendersonville, Tennessee 37075 Phone: (615) 822-8888 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 206 Indian Lake Blvd, Hendersonville, Tennessee 37075 Phone: (615) 868-7626 | |
Kroger Pharmacy #619 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 237 E Main St, Hendersonville, Tennessee 37075 Phone: (615) 822-6797 | |
Kroger Pharmacy L571 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1010 Glenbrook Way, Hendersonville, Tennessee 37075 Phone: (615) 822-1138 |